bacteriuria
bacteriuria
Explore linked clinical trials. Standard reference: MONDO:00018823 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Prediction and Prevention of Bloodstream Infections After Kidney Transplantation | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infections, Inflammation, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, Urogenital Diseases, bacteriuria, urinary system disorder, urinary tract infection | Not yet recruiting | Phase 3 | 2026-07-22 | NCT07407673 | |
| Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria | Bacterial Infections and Mycoses, Enterobacteriaceae Infections, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infections, Male Urogenital Diseases, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urinary Bladder, Neurogenic, Urogenital Diseases, bacterial infectious disease, bacteriuria, central nervous system disorder, escherichia coli infection, gram-negative bacterial infections, injury, nervous system disorder, nervous system injury, spinal cord disorder, spinal cord injury, urinary bladder disorder, urinary system disorder, urinary tract infection | Recruiting | Phase 1 | 2026-05-05 | NCT06559618 | |
| Asymptomatic Bacteriuria in Pregnancy in Low- and Middle-IncomE Countries | Death, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Fetal Death, Infections, Male Urogenital Diseases, Obstetric Labor Complications, Obstetric Labor, Premature, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Premature Birth, Urogenital Diseases, bacteriuria, pregnancy disorder, pregnancy disorder with abortive outcome, urinary system disorder, urinary tract infection | Recruiting | Phase 3 | 2026-01-22 | NCT06723392 |